---
layout: post
title: "Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:58:03 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-02858
original_published: 2022-02-10 00:00:00 +0000
significance: 8.00
---

# Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** February 10, 2022 00:00 UTC
**Document Number:** 2022-02858

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Development of Non-Opioid Analgesics for Acute Pain." In connection with the SUPPORT for Patients and Communities Act (SUPPORT Act), the purpose of this guidance is to spur the development of alternatives to opioids for the management of acute pain by providing information about product development-related issues, "opioid-sparing" claims, and expedited programs as they pertain to this purpose.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/02/10/2022-02858/development-of-non-opioid-analgesics-for-acute-pain-draft-guidance-for-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-02858

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
